Treatment | Dysplasia | Adenoma | Adenocarcinoma | Tumora |
---|---|---|---|---|
Non-treatment | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
Vehicleb + 4% DSS | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
AAT (125 mg/kg/day) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
AAT (125 mg/kg/day) + 4% DSS | 0.9 ± 0.6*** | 3.8 ± 1.2*** | 4.1 ± 1.7*** | 7.9 ± 2.0*** |
DMBA (25 mg/kg/day) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
DMBA (25 mg/kg/day) + 4% DSS | 1.0 ± 1.1** | 1.5 ± 2.0* | 1.5 ± 1.6** | 3.0 ± 1.9*** |
ENU (11 mg/kg/day) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
ENU (11 mg/kg/day) + 4% DSS | 1.6 ± 0.5*** | 4.9 ± 1.9*** | 3.7 ± 1.5*** | 8.6 ± 1.1*** |